Workflow
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results

Exact Sciences Corporation (NASDAQ:EXAS) reported better-than-expected third-quarter financial results and raised its FY25 sales guidance above estimates on Monday.Exact Sciences reported quarterly earnings of 24 cents per share which beat the analyst consensus estimate of a loss of 7 cents per share. The company reported quarterly sales of 850.739millionwhichbeattheanalystconsensusestimateof850.739 million which beat the analyst consensus estimate of 810.178 million.Exact Sciences raised its FY2025 sales guidance from 3.130billion3.130 billion-3.170 billion to $3.2 ...